ROS-mediated inactivation of the PI3K/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin
Chuangyu Wen(University of Chicago), Junsheng Peng(Guangzhou University of Chinese Medicine)
Cited by 129
Related Papers
Establishment and evaluation of four different types of patient-derived xenograft models
|Cancer Cell International|2017|27
YTHDF1 loss in dendritic cells potentiates radiation-induced antitumor immunity via STING-dependent type I IFN production
|Journal of Clinical Investigation|2024|21
The Advantages of Mesenchymal Stem Cell-Derived Extracellular Vesicles as Drug Delivery Systems
|Stem Cell Reviews and Reports|2025|3